Top Of The Line: IBD 50's Five Best For Sales Growth

Investors naturally focus on earnings, because over the long term they are the biggest driver of stock performance. But top-line gains reflect robust demand and quickly filter down to the bottom line. It's no coincidence that 40 of the elite IBD 50 companies have sales growth of at least 20%. Here are the top 5 IBD stocks based on revenue growth. As you'll see, these sales standouts enjoy huge earnings per share. Questcor Pharmaceuticals (QCOR)